New SEC Form D filing
Biosceptre International Ltd, 2026-07-28
A new SEC Form D private-offering notice from Cambridge, a $345,981 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Cambridge, UK biopharmaceutical company developing CAR T and antibody based cancer therapies targeting nfP2X7
Filed 2026-07-28Filed to raise $345,981First money in 2026-06-25Raised so far $345,981HQ (as filed) CambridgeSector Biotech web-verified against the company’s own siteStage (inferred) Pre-seedCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified biosceptre.com↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR sourceThe Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.